Clinical efficacy of a benazepril and spironolactone combination in dogs with congestive heart failure due to myxomatous mitral valve disease: The BEnazepril Spironolactone STudy (BESST)

Clinical efficacy of a benazepril and spironolactone combination in dogs with congestive heart failure due to myxomatous mitral valve disease: The BEnazepril Spironolactone STudy (BESST)

Abstract Background The renin‐angiotensin‐aldosterone system (RAAS), when chronically activated, is harmful and RAAS‐suppressive drugs are beneficial in the treatment of congestive heart failure (CHF). Mineralocorticoid receptor antagonists are widely used in the treatment of CHF in people. Hypothes...

Full description

Bibliographic Details
Main Authors: Melissa Coffman, Emilie Guillot, Thomas Blondel, Catherine Garelli‐Paar, Shuo Feng, Susanne Heartsill, Clarke E. Atkins
Format: Article
Language:English
Published: Wiley 2021-07-01
Series:Journal of Veterinary Internal Medicine
Subjects:
ACE inhibitor
aldosterone breakthrough
mitral regurgitation
MRA
RAAS
Online Access:https://doi.org/10.1111/jvim.16155

Internet

https://doi.org/10.1111/jvim.16155

Similar Items